X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10887) 10887
Newspaper Article (876) 876
Newsletter (352) 352
Book Chapter (124) 124
Magazine Article (118) 118
Dissertation (44) 44
Reference (42) 42
Book / eBook (38) 38
Transcript (14) 14
Conference Proceeding (13) 13
Government Document (9) 9
Book Review (8) 8
Web Resource (8) 8
Publication (5) 5
Streaming Video (5) 5
Video Recording (2) 2
Archival Material (1) 1
Journal / eJournal (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7802) 7802
thalidomide (6175) 6175
science & technology (6144) 6144
life sciences & biomedicine (5977) 5977
thalidomide - therapeutic use (3982) 3982
female (3854) 3854
male (3745) 3745
thalidomide - analogs & derivatives (2960) 2960
middle aged (2571) 2571
thalidomide - adverse effects (2387) 2387
thalidomide - administration & dosage (2221) 2221
aged (2218) 2218
multiple myeloma - drug therapy (2160) 2160
oncology (2071) 2071
multiple myeloma (2000) 2000
adult (1974) 1974
hematology (1968) 1968
animals (1721) 1721
treatment outcome (1640) 1640
thalidomide - pharmacology (1452) 1452
antineoplastic combined chemotherapy protocols - therapeutic use (1367) 1367
lenalidomide (1193) 1193
bortezomib (1063) 1063
antineoplastic agents - therapeutic use (1000) 1000
care and treatment (930) 930
research (867) 867
abridged index medicus (851) 851
aged, 80 and over (841) 841
pharmacology & pharmacy (798) 798
drug therapy (786) 786
aids/hiv (776) 776
pregnancy (774) 774
dexamethasone - administration & dosage (768) 768
angiogenesis inhibitors - therapeutic use (755) 755
immunosuppressive agents - therapeutic use (734) 734
cancer (685) 685
mice (625) 625
multiple myeloma - pathology (550) 550
recurrence (540) 540
dexamethasone (526) 526
abnormalities, drug-induced (519) 519
antineoplastic combined chemotherapy protocols - adverse effects (518) 518
medicine & public health (510) 510
prognosis (504) 504
dermatology (499) 499
health aspects (497) 497
multiple myeloma - mortality (471) 471
analysis (470) 470
chemotherapy (467) 467
dose-response relationship, drug (467) 467
multiple myeloma - therapy (455) 455
disease-free survival (450) 450
rats (448) 448
clinical trials as topic (434) 434
general & internal medicine (433) 433
drug therapy, combination (431) 431
old medline (431) 431
medicine, general & internal (422) 422
immunologic factors - therapeutic use (413) 413
retrospective studies (413) 413
toxicology (401) 401
remission induction (389) 389
antineoplastic agents - adverse effects (374) 374
risk factors (373) 373
immunology (370) 370
follow-up studies (368) 368
hematology, oncology and palliative medicine (363) 363
transplantation (361) 361
antineoplastic combined chemotherapy protocols - administration & dosage (352) 352
dosage and administration (352) 352
dexamethasone - therapeutic use (351) 351
time factors (348) 348
clinical trials (345) 345
angiogenesis (340) 340
survival analysis (337) 337
boronic acids - administration & dosage (333) 333
adolescent (332) 332
pyrazines - administration & dosage (332) 332
medical research (326) 326
boronic acids - therapeutic use (322) 322
pyrazines - therapeutic use (322) 322
disease progression (321) 321
survival rate (321) 321
child (320) 320
myelodysplastic syndromes - drug therapy (314) 314
combined modality therapy (312) 312
multiple myeloma - complications (312) 312
multiple myeloma - diagnosis (310) 310
thalidomide - toxicity (309) 309
transplantation, autologous (303) 303
patients (300) 300
myeloma (298) 298
drug administration schedule (296) 296
stem cells (296) 296
antineoplastic agents - pharmacology (295) 295
angiogenesis inhibitors (292) 292
stem cell transplantation (290) 290
antineoplastic agents - administration & dosage (284) 284
drugs (279) 279
hematopoietic stem cell transplantation (275) 275
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (17) 17
Robarts - Stacks (9) 9
UTL at Downsview - May be requested (7) 7
Online Resources - Online (5) 5
OISE - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
Trinity College (John W Graham) - Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Holland Bloorview Kids Rehabilitation - Stacks (2) 2
Law (Bora Laskin) - Stacks (2) 2
Media Commons - Audio Visual (2) 2
UofT at Mississauga - Stacks (2) 2
Criminology - Stacks (1) 1
East Asian (Cheng Yu Tung) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Law (Bora Laskin) - May be requested in 6-10 wks (1) 1
Music - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
OISE - May be requested in 6-10 wks (1) 1
St. Augustine's Seminary - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11098) 11098
German (445) 445
Japanese (281) 281
French (270) 270
Chinese (149) 149
Spanish (124) 124
Portuguese (107) 107
Italian (91) 91
Polish (60) 60
Czech (56) 56
Swedish (34) 34
Korean (29) 29
Dutch (25) 25
Russian (18) 18
Danish (14) 14
Hungarian (12) 12
Norwegian (8) 8
Finnish (7) 7
Hebrew (7) 7
Turkish (5) 5
Slovak (4) 4
Ukrainian (4) 4
Romanian (3) 3
Persian (2) 2
Serbian (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 05/2012, Volume 366, Issue 19, pp. 1782 - 1791
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2010, Volume 363, Issue 11, pp. 1025 - 1037
This study shows that even in patients with del(5q) myelodysplastic syndrome who become transfusion-independent in response to lenalidomide, a myelo-dysplastic... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | ADP-ribosyl Cyclase 1 - analysis | Antigens, CD34 - analysis | Neoplastic Stem Cells - drug effects | Humans | Middle Aged | Neoplastic Stem Cells - immunology | Male | Antineoplastic Agents - therapeutic use | Thalidomide - pharmacology | Thalidomide - analogs & derivatives | Aged, 80 and over | Female | Antineoplastic Agents - pharmacology | Myelodysplastic Syndromes - drug therapy | Chromosomes, Human, Pair 5 - genetics | Chromosome Deletion | Gene Expression | Remission Induction | Drug Resistance - genetics | Phenotype | Aged | Myelodysplastic Syndromes - genetics | Thalidomide - therapeutic use | Myelodysplastic Syndromes - pathology | Thy-1 Antigens - analysis | Stem cells | Physiological aspects | Chromosome deletion | Genetic aspects | Diagnosis | Research | Health aspects | Myelodysplastic syndromes | Bone marrow | Patients | Cancer | Index Medicus | Abridged Index Medicus | Thalidomide: therapeutic use | Myelodysplastic Syndromes: pathology | Neoplastic Stem Cells: drug effects | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinsk genetik | Medical Genetics | Antineoplastic Agents: pharmacology | Thalidomide: analogs & derivatives | Myelodysplastic Syndromes: genetics | CD34: analysis | Chromosomes | Pair 5: genetics | Human | Antigens | Basic Medicine | Thy-1: analysis | Cell and Molecular Biology | Drug Resistance: genetics | CD38: analysis | Thalidomide: pharmacology | Neoplastic Stem Cells: immunology | Medicinska och farmaceutiska grundvetenskaper | Antineoplastic Agents: therapeutic use | Myelodysplastic Syndromes: drug therapy | Cell- och molekylärbiologi
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2014, Volume 371, Issue 10, pp. 906 - 917
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2017, Volume 376, Issue 14, pp. 1311 - 1320
Journal Article
Journal Article
Blood, ISSN 1528-0020, 08/2012, Volume 120, Issue 8, pp. 1589 - 1596
The Spanish Myeloma Group conducted a trial to compare bortezomib/thalidomide/dexamethasone (VTD) versus thalidomide/dexamethasone (TD) versus vincristine,... 
Life Sciences & Biomedicine | Hematology | Science & Technology | Boronic Acids - toxicity | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Pyrazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Boronic Acids - adverse effects | Dexamethasone - adverse effects | Dexamethasone - toxicity | Induction Chemotherapy | Male | Transplantation, Autologous | Antineoplastic Agents - therapeutic use | Pyrazines - therapeutic use | Antineoplastic Agents - administration & dosage | Boronic Acids - therapeutic use | Antineoplastic Agents - toxicity | Multiple Myeloma - therapy | Pyrazines - toxicity | Antineoplastic Agents - adverse effects | Female | Boronic Acids - administration & dosage | Thalidomide - adverse effects | Bortezomib | Dexamethasone - administration & dosage | Multiple Myeloma - diagnosis | Thalidomide - administration & dosage | Thalidomide - toxicity | Antineoplastic Combined Chemotherapy Protocols - toxicity | Disease-Free Survival | Dexamethasone - therapeutic use | Multiple Myeloma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrazines - adverse effects | Stem Cells - drug effects | Stem Cells - pathology | Aged | Hematopoietic Stem Cell Transplantation - methods | Thalidomide - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 1528-0020, 11/2011, Volume 118, Issue 18, pp. 4771 - 4779
Journal Article